Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2012. The document serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) rather than a comprehensive financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific share transaction.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The only reported activity is the exercise and subsequent sale of share options by a senior executive.
Management Commentary and Risks
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this specific filing. The document is a statutory disclosure of a director's transaction under Disclosure Rule 3.1.4R(1)(a).
Important Facts for Investors
- Executive Transaction: Mr. E J Gray exercised options over 54,000 Ordinary Shares granted on December 3, 2002.
- Transaction Details: The exercise price was £11.79 per share, and the shares were immediately sold at £15.016 per share.
- Timing: The transaction occurred on August 8, 2012, and was notified to the company on August 9, 2012.
- Financial Data: This filing contains no consolidated financial results for the company.